New York, NEW%20YORK2 Active Studies

Antiphospholipid Syndrome Clinical Trials in New York, NEW%20YORK

Find 2 actively recruiting antiphospholipid syndrome clinical trials in New York, NEW%20YORK. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
77
Enrolling

Recruiting Antiphospholipid Syndrome Studies in New York

About Antiphospholipid Syndrome Clinical Trials in New York

Antiphospholipid syndrome is an autoimmune disorder that increases the risk of blood clots in arteries and veins, and pregnancy complications. It occurs when the immune system makes antibodies that attack phospholipids. Treatment primarily involves anticoagulant medications.

There are currently 2 antiphospholipid syndrome clinical trials recruiting participants in New York, NEW%20YORK. These studies are seeking a combined 77 participants. Research is being sponsored by David Ware Branch, National Institute of Allergy and Infectious Diseases (NIAID). Clinical trial participation is free and participants receive study-related medical care at no cost.

Antiphospholipid Syndrome Clinical Trials in New York — FAQ

Are there antiphospholipid syndrome clinical trials in New York?

Yes, there are 2 antiphospholipid syndrome clinical trials currently recruiting in New York, NEW%20YORK. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New York?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.

Are clinical trials in New York free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.

What antiphospholipid syndrome treatments are being tested?

The 2 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for antiphospholipid syndrome.

Data updated March 2, 2026 from ClinicalTrials.gov